Tonix Pharma (TNXP) Reports Completion of Positive Pre-IND Meeting with FDA for TNX-102 SL (Cyclobenzaprine HCI Sublingual Tablets)
Tweet Send to a Friend
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) announced today that it recently held a pre-Investigational New Drug (IND) meeting with the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
